| 1 |
TUBB3
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
| 2 |
TUBB3
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
| 3 |
TUBB3
| [1] Salmonella infection Salmonella infection | D01068
D01068
|
Vinblastine
| [2] 34 34, 65 |
| 4 |
TUBB3
| [1] Salmonella infection Salmonella infection | D02197
D02197
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 5 |
TUBB3
| [1] Salmonella infection Salmonella infection | D05333
D05333
|
Paclitaxel
| [2] 46 46, 85 |
| 6 |
TUBB3
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
| 7 |
TUBB3
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 8 |
TUBB3
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
| 9 |
TUBB3
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
| 10 |
TUBB4A
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
| 11 |
TUBB4A
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
| 12 |
TUBB4A
| [1] Salmonella infection Salmonella infection | D01068
D01068
|
Vinblastine
| [2] 34 34, 65 |
| 13 |
TUBB4A
| [1] Salmonella infection Salmonella infection | D02197
D02197
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 14 |
TUBB4A
| [1] Salmonella infection Salmonella infection | D05333
D05333
|
Paclitaxel
| [2] 46 46, 85 |
| 15 |
TUBB4A
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
| 16 |
TUBB4A
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 17 |
TUBB4A
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
| 18 |
TUBB4A
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
| 19 |
TUBB4B
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
| 20 |
TUBB4B
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
| 21 |
TUBB4B
| [1] Salmonella infection Salmonella infection | D01068
D01068
|
Vinblastine
| [2] 34 34, 65 |
| 22 |
TUBB4B
| [1] Salmonella infection Salmonella infection | D02197
D02197
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 23 |
TUBB4B
| [1] Salmonella infection Salmonella infection | D05333
D05333
|
Paclitaxel
| [2] 46 46, 85 |
| 24 |
TUBB4B
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
| 25 |
TUBB4B
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 26 |
TUBB4B
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
| 27 |
TUBB4B
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
| 28 |
MAPK14
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| [2] 113 113, 222 |
| 29 |
MAPK14
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| [1] 8 8 |
| 30 |
TUBB
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
| 31 |
TUBB
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
| 32 |
TUBB
| [1] Salmonella infection Salmonella infection | D01068
D01068
|
Vinblastine
| [2] 34 34, 65 |
| 33 |
TUBB
| [1] Salmonella infection Salmonella infection | D02197
D02197
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 34 |
TUBB
| [1] Salmonella infection Salmonella infection | D05333
D05333
|
Paclitaxel
| [2] 46 46, 85 |
| 35 |
TUBB
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
| 36 |
TUBB
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 37 |
TUBB
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
| 38 |
TUBB
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
| 39 |
TUBB8
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
| 40 |
TUBB8
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
| 41 |
TUBB8
| [1] Salmonella infection Salmonella infection | D01068
D01068
|
Vinblastine
| [2] 34 34, 65 |
| 42 |
TUBB8
| [1] Salmonella infection Salmonella infection | D02197
D02197
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 43 |
TUBB8
| [1] Salmonella infection Salmonella infection | D05333
D05333
|
Paclitaxel
| [2] 46 46, 85 |
| 44 |
TUBB8
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
| 45 |
TUBB8
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 46 |
TUBB8
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
| 47 |
TUBB8
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
| 48 |
TUBB2B
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
| 49 |
TUBB2B
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
| 50 |
TUBB2B
| [1] Salmonella infection Salmonella infection | D01068
D01068
|
Vinblastine
| [2] 34 34, 65 |
| 51 |
TUBB2B
| [1] Salmonella infection Salmonella infection | D02197
D02197
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 52 |
TUBB2B
| [1] Salmonella infection Salmonella infection | D05333
D05333
|
Paclitaxel
| [2] 46 46, 85 |
| 53 |
TUBB2B
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
| 54 |
TUBB2B
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 55 |
TUBB2B
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
| 56 |
TUBB2B
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
| 57 |
IL1B
| [8] Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Tuberculosis | D01583
D01583
|
Pirfenidone
| [11] 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 58 |
IL1B
| [8] Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Tuberculosis | D06635
D06635
|
Rilonacept
| [4] 51 51, 106, 107, 266 |
| 59 |
IL1B
| [8] Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Tuberculosis | D09315
D09315
|
Canakinumab
| [10] 46 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 |
| 60 |
IL1B
| [8] Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Tuberculosis | D09911
D09911
|
Gevokizumab
| [4] 41 41, 50, 56, 269 |
| 61 |
IL6
| [8] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer | D01583
D01583
|
Pirfenidone
| [11] 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 62 |
IL6
| [8] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer | D08976
D08976
|
Pomalidomide
| [6] 28 28, 34, 51, 85, 227, 331 |
| 63 |
IL6
| [8] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer | D09669
D09669
|
Siltuximab
| [2] 28 28, 331 |
| 64 |
IL6
| [8] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Salmonella infection, Yersinia infection, Tuberculosis, Transcriptional misregulation in cancer | D10080
D10080
|
Sirukumab
| [2] 41 41, 46 |
| 65 |
NFKB1
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Small cell lung cancer | D01146
D01146
|
Iguratimod
| [4] 46 46, 51, 53, 271 |
| 66 |
PIK3CA
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Small cell lung cancer | D11158
D11158
|
Leniolisib
| [2] 53 53, 65 |
| 67 |
PIK3CB
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Small cell lung cancer | D11158
D11158
|
Leniolisib
| [2] 53 53, 65 |
| 68 |
PIK3CD
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Small cell lung cancer | D11158
D11158
|
Leniolisib
| [2] 53 53, 65 |
| 69 |
PIK3CD
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Small cell lung cancer | D11437
D11437
|
Parsaclisib
| [3] 35 35, 53, 61 |
| 70 |
MAPK11
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| [2] 113 113, 222 |
| 71 |
MAPK11
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| [1] 8 8 |
| 72 |
MAPK13
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| [2] 113 113, 222 |
| 73 |
MAPK13
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| [1] 8 8 |
| 74 |
MAP2K1
| [12] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D09666
D09666
|
Selumetinib
| [1] 34 34 |
| 75 |
MAP2K1
| [12] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D10175
D10175
|
Trametinib
| [4] 2 2, 34, 279, 280 |
| 76 |
MAP2K1
| [12] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D10405
D10405
|
Cobimetinib
| [1] 280 280 |
| 77 |
MAP2K1
| [12] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D10604
D10604
|
Binimetinib
| [1] 34 34 |
| 78 |
MAP2K2
| [10] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D09666
D09666
|
Selumetinib
| [1] 34 34 |
| 79 |
MAP2K2
| [10] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D10175
D10175
|
Trametinib
| [4] 2 2, 34, 279, 280 |
| 80 |
MAP2K2
| [10] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D10405
D10405
|
Cobimetinib
| [1] 280 280 |
| 81 |
MAP2K2
| [10] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Thyroid cancer | D10604
D10604
|
Binimetinib
| [1] 34 34 |
| 82 |
RAF1
| [9] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Tuberculosis | D06272
D06272
|
Sorafenib
| [2] 34 34, 86 |
| 83 |
RAF1
| [9] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Tuberculosis | D08524
D08524
|
Sorafenib
| [2] 34 34, 86 |
| 84 |
BCL2
| [6] Sphingolipid signaling pathway Sphingolipid signaling pathway, Shigellosis, Salmonella infection, Toxoplasmosis, Tuberculosis, Small cell lung cancer | D10679
D10679
|
Venetoclax
| [1] 28 28 |
| 85 |
RELA
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Small cell lung cancer | D12181
D12181
|
Edasalonexent
| [1] 113 113 |
| 86 |
MAPK12
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| [2] 113 113, 222 |
| 87 |
MAPK12
| [14] Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| [1] 8 8 |
| 88 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D00742
D00742
|
Etanercept
| [17] 15 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285, 298 |
| 89 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D00754
D00754
|
Thalidomide
| [20] 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
| 90 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D01583
D01583
|
Pirfenidone
| [11] 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 91 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D02597
D02597
|
Adalimumab
| [18] 19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 151, 160, 164, 222, 226, 269, 270, 271 |
| 92 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D02598
D02598
|
Infliximab
| [27] 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 |
| 93 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D03441
D03441
|
Certolizumab pegol
| [8] 37 37, 46, 49, 96, 97, 107, 226, 271 |
| 94 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D04358
D04358
|
Golimumab
| [8] 46 46, 56, 84, 96, 97, 107, 270, 271 |
| 95 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D04687
D04687
|
Lenalidomide
| [8] 16 16, 26, 28, 34, 49, 284, 300, 331 |
| 96 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D05393
D05393
|
Pegsunercept
| [1] 46 46 |
| 97 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D08976
D08976
|
Pomalidomide
| [6] 28 28, 34, 51, 85, 227, 331 |
| 98 |
TNF
| [14] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Salmonella infection, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D09944
D09944
|
Ozoralizumab
| [1] 46 46 |
| 99 |
TUBB2A
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
| 100 |
TUBB2A
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
| 101 |
TUBB2A
| [1] Salmonella infection Salmonella infection | D01068
D01068
|
Vinblastine
| [2] 34 34, 65 |
| 102 |
TUBB2A
| [1] Salmonella infection Salmonella infection | D02197
D02197
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 103 |
TUBB2A
| [1] Salmonella infection Salmonella infection | D05333
D05333
|
Paclitaxel
| [2] 46 46, 85 |
| 104 |
TUBB2A
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
| 105 |
TUBB2A
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 106 |
TUBB2A
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
| 107 |
TUBB2A
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
| 108 |
TUBB1
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
| 109 |
TUBB1
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
| 110 |
TUBB1
| [1] Salmonella infection Salmonella infection | D01068
D01068
|
Vinblastine
| [2] 34 34, 65 |
| 111 |
TUBB1
| [1] Salmonella infection Salmonella infection | D02197
D02197
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 112 |
TUBB1
| [1] Salmonella infection Salmonella infection | D05333
D05333
|
Paclitaxel
| [2] 46 46, 85 |
| 113 |
TUBB1
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
| 114 |
TUBB1
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 115 |
TUBB1
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
| 116 |
TUBB1
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
| 117 |
TUBB6
| [1] Salmonella infection Salmonella infection | D00491
D00491
|
Paclitaxel
| [2] 46 46, 85 |
| 118 |
TUBB6
| [1] Salmonella infection Salmonella infection | D00570
D00570
|
Colchicine
| [7] 2 2, 42, 46, 56, 93, 210, 266 |
| 119 |
TUBB6
| [1] Salmonella infection Salmonella infection | D01068
D01068
|
Vinblastine
| [2] 34 34, 65 |
| 120 |
TUBB6
| [1] Salmonella infection Salmonella infection | D02197
D02197
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 121 |
TUBB6
| [1] Salmonella infection Salmonella infection | D05333
D05333
|
Paclitaxel
| [2] 46 46, 85 |
| 122 |
TUBB6
| [1] Salmonella infection Salmonella infection | D08675
D08675
|
Vinblastine
| [2] 34 34, 65 |
| 123 |
TUBB6
| [1] Salmonella infection Salmonella infection | D08679
D08679
|
Vincristine
| [4] 26 26, 34, 65, 331 |
| 124 |
TUBB6
| [1] Salmonella infection Salmonella infection | D09587
D09587
|
Brentuximab vedotin
| [2] 49 49, 51 |
| 125 |
TUBB6
| [1] Salmonella infection Salmonella infection | D11595
D11595
|
Belantamab mafodotin
| [1] 28 28 |
| 126 |
ROCK2
| [7] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, Tight junction, Shigellosis, Salmonella infection, Yersinia infection | D07941
D07941
|
Fasudil
| [4] 2 2, 5, 7, 51 |
| 127 |
ROCK2
| [7] Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, Tight junction, Shigellosis, Salmonella infection, Yersinia infection | D11815
D11815
|
Belumosudil
| [1] 51 51 |